ANDREW VALADEZ: Open Payments
NPI 1366111882 · WALNUT CREEK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$859 in 30 payments from 13 companies in 2025. Trend: 2023 $95 · 2024 $524 · 2025 $859
Food & beverage: $859
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $230 |
| UCB, Inc. | 3 | $108 |
| Janssen Biotech, Inc. | 2 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $90 |
| Vanda Pharmaceuticals Inc. | 2 | $67 |
| Janssen Pharmaceuticals, Inc | 2 | $65 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Lundbeck LLC | 1 | $35 |
| Eisai Inc. | 1 | $30 |
| Lilly USA, LLC | 1 | $28 |
Products named: VRAYLAR, Nayzilam, RYBREVANT, CAPLYTA, QULIPTA, SPRAVATO, FANAPT, REXULTI.
Industry payments across CA — which companies pay providers there.
